- Home
- CHEF vs TERN Comparison
CHEF vs TERN Comparison
Compare CHEF & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHEF | TERN |
|---|---|---|
| Founded | 1985 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CHEF | TERN |
|---|---|---|
| Price | $59.55 | $27.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $70.33 | $25.59 |
| AVG Volume (30 Days) | 404.5K | ★ 5.6M |
| Earning Date | 10-29-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.09 | N/A |
| EPS | ★ 1.73 | N/A |
| Revenue | ★ $4,040,541,000.00 | N/A |
| Revenue This Year | $10.22 | N/A |
| Revenue Next Year | $7.10 | N/A |
| P/E Ratio | $35.48 | ★ N/A |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $43.83 | $1.87 |
| 52 Week High | $68.94 | $29.51 |
Technical Indicators
Market Signals| Indicator | CHEF | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 74.11 |
| Support Level | $56.47 | $25.31 |
| Resistance Level | $63.36 | $29.51 |
| Average True Range (ATR) | 2.20 | 1.95 |
| MACD | 0.10 | 0.08 |
| Stochastic Oscillator | 44.78 | 81.51 |
Price Performance
Historical ComparisonAbout CHEF The Chefs' Warehouse Inc.
The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.